title: Primary EBV infection resulting in lymphoproliferative disease in a teenager with Crohn disease.
authors.affiliation: Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta, USA.
authors.forename: Dominica
authors.initials: D
authors.lastname: Gidrewicz
authors.forename: Deborah
authors.initials: D
authors.lastname: Lehman
authors.forename: Shervin
authors.initials: S
authors.lastname: Rabizadeh
authors.forename: Fataneh
authors.initials: F
authors.lastname: Majlessipour
authors.forename: Marla
authors.initials: M
authors.lastname: Dubinsky
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab; D008232:Lymphoproliferative Disorders / Q000150:complications*; D008775:Methylprednisolone / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine; D008775:Methylprednisolone